 |
3-[2-(4-carbamimidoyl-phenylcarbamoyl)-5-methoxy-4-vinyl-phenyl]-6-(cyclopropylmethyl-carbamoyl)-pyridine-2-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Hereditary angioedema |
| EU Market Approval | EU |
| EU Designation Date | 2015-02-12 00:00:00 |
| Sponsor | BioCryst UK Ltd. |
Related Access Program